Abstract: The invention concerns compounds of formula (I) and their salts, as defined into claim 1 and their uses, in particular in PCR applications.
| # | Name | Date |
|---|---|---|
| 1 | 202517048621-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [20-05-2025(online)].pdf | 2025-05-20 |
| 2 | 202517048621-STATEMENT OF UNDERTAKING (FORM 3) [20-05-2025(online)].pdf | 2025-05-20 |
| 3 | 202517048621-REQUEST FOR EXAMINATION (FORM-18) [20-05-2025(online)].pdf | 2025-05-20 |
| 4 | 202517048621-PROOF OF RIGHT [20-05-2025(online)].pdf | 2025-05-20 |
| 5 | 202517048621-PRIORITY DOCUMENTS [20-05-2025(online)].pdf | 2025-05-20 |
| 6 | 202517048621-POWER OF AUTHORITY [20-05-2025(online)].pdf | 2025-05-20 |
| 7 | 202517048621-FORM 18 [20-05-2025(online)].pdf | 2025-05-20 |
| 8 | 202517048621-FORM 1 [20-05-2025(online)].pdf | 2025-05-20 |
| 9 | 202517048621-DRAWINGS [20-05-2025(online)].pdf | 2025-05-20 |
| 10 | 202517048621-DECLARATION OF INVENTORSHIP (FORM 5) [20-05-2025(online)].pdf | 2025-05-20 |
| 11 | 202517048621-COMPLETE SPECIFICATION [20-05-2025(online)].pdf | 2025-05-20 |
| 12 | 202517048621-FORM 3 [07-11-2025(online)].pdf | 2025-11-07 |